Free Cash Flow Chart

Historical Free Cash Flow Data

View and export this data back to 2005. Start Trial.
Date Value
June 30, 2026 -0.8494M
December 31, 2025 -43.53M
June 30, 2025 -47.55M
December 31, 2024 -40.92M
June 30, 2024 26.76M
December 31, 2023 27.18M
June 30, 2023 -39.46M
December 31, 2022 -35.28M
June 30, 2022 -33.01M
December 31, 2021 -40.88M
June 30, 2021 -46.55M
December 31, 2020 -46.53M
June 30, 2020 2.391M
December 31, 2019 2.641M
June 30, 2019 -56.70M
December 31, 2018 -60.67M
June 30, 2018 -46.17M
December 31, 2017 -41.71M
June 30, 2017 -33.93M
December 31, 2016 -27.93M
June 30, 2016 -29.73M
Date Value
December 31, 2015 -23.66M
June 30, 2015 -11.47M
December 31, 2014 -6.834M
June 30, 2014 -6.190M
December 31, 2013 -7.515M
June 30, 2013 -8.390M
December 31, 2012 -11.69M
June 30, 2012 -17.69M
December 31, 2011 -22.48M
June 30, 2011 -5.354M
December 31, 2010 -5.667M
June 30, 2010 -12.16M
December 31, 2009 -18.51M
June 30, 2009 -38.07M
December 31, 2008 -43.19M
June 30, 2008 -28.78M
December 31, 2007 -16.84M
June 30, 2007 -23.22M
December 31, 2006 -20.05M
June 30, 2006 -4.991M
December 31, 2005 -5.438M

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
Basilea Pharmaceutica AG 71.34M
BeOne Medicines Ltd. 1.333B
AC Immune SA --
CRISPR Therapeutics AG -371.32M
Idorsia Ltd. -172.44M

Free Cash Flow Related Metrics